Copyright
©The Author(s) 2025.
World J Radiol. Mar 28, 2025; 17(3): 100168
Published online Mar 28, 2025. doi: 10.4329/wjr.v17.i3.100168
Published online Mar 28, 2025. doi: 10.4329/wjr.v17.i3.100168
Table 1 Patients’ characteristics, n = 77
| Variable | |
| Female | 35 |
| Age at diagnosis, years (SD-IQR) | 42 (12-46) |
| Time from diagnosis, years (SD-IQR) | 9.9 (7.2-25) |
| Microadenoma, n (%) | 26 (32) |
| Macroadenoma, n (%) | 51 (66) |
| T2 weighted hyperintensity, n (%) | 16 (20) |
| Adenoma volume, mm3 (SD-IQR) | 4358 (6291-13602) |
| Vertical extension (supraselar or sphenoid sinus), n (%) | 22 (29) |
| Horizontal extension (cavernous sinus), n (%) | 20 (27) |
| IGF-1 at diagnosis, ng/mL (SD-IQR) | 564.6 (334-859) |
| IGF-1 after surgery, ng/mL, (SD-IQR) | 331 (198-478) |
| Treatment line 0 (No surgical therapy), n (%) | 12 (15) |
| Treatment line 1, n (%) | 16 (20) |
| Treatment line 2, n (%) | 20 (25) |
| Treatment line 3, n (%) | 16 (20) |
| Treatment line 4, n (%) | 13 (16) |
| Controlled disease, n (%) | 44 (57) |
| Uncontrolled disease, n (%) | 33 (42) |
- Citation: Alvarez M, Donato A, Rincon J, Rincon O, Lancheros N, Mancera P, Guzman I. Evaluation of pituitary tumor volume as a prognostic factor in acromegaly: A cross-sectional study in two centers. World J Radiol 2025; 17(3): 100168
- URL: https://www.wjgnet.com/1949-8470/full/v17/i3/100168.htm
- DOI: https://dx.doi.org/10.4329/wjr.v17.i3.100168